mRNA levels of ESR1 and HER2 as predictive and prognostic markers of breast cancer

被引：0
|
作者：
Park, In Hae [1 ]
Ro, Jungsil [1 ]
机构：
[1] Natl Canc Ctr, Ctr Breast Canc, Kashiwa, Chiba, Japan
来源：
PHARMACOGENOMICS | 2013年 / 14卷 / 11期
关键词：
BEVACIZUMAB; EXPRESSION; THERAPY;
D O I：
10.2217/pgs.13.101
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1251 / 1253
页数：3
相关论文
共 50 条
  • [1] HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
    Denkert, Carsten
    Huober, Jens
    Loibl, Sibylle
    Prinzler, Judith
    Kronenwett, Ralf
    Darb-Esfahani, Silvia
    Brase, Jan C.
    Solbach, Christine
    Mehta, Keyur
    Fasching, Peter A.
    Sinn, Bruno V.
    Engels, Knut
    Reinisch, Mattea
    Hansmann, Martin-Leo
    Tesch, Hans
    von Minckwitz, Gunter
    Untch, Michael
    BREAST CANCER RESEARCH, 2013, 15 (01)
  • [2] HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
    Carsten Denkert
    Jens Huober
    Sibylle Loibl
    Judith Prinzler
    Ralf Kronenwett
    Silvia Darb-Esfahani
    Jan C Brase
    Christine Solbach
    Keyur Mehta
    Peter A Fasching
    Bruno V Sinn
    Knut Engels
    Mattea Reinisch
    Martin-Leo Hansmann
    Hans Tesch
    Gunter von Minckwitz
    Michael Untch
    Breast Cancer Research, 15
  • [3] Correlation of ER (ESR1), PR (PGR), and HER2 (ERBB2) at protein and mRNA levels in operable breast cancer
    Lei, Lei
    Wang, Xiaojia
    Cheng, Skye Hung-Chun
    CANCER RESEARCH, 2022, 82 (04)
  • [4] HER2 as a prognostic and predictive marker for breast cancer
    Cooke, T
    Reeves, J
    Lanigan, A
    Stanton, P
    ANNALS OF ONCOLOGY, 2001, 12 : 23 - 28
  • [5] Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
    Kriegmair, M. C.
    Wirtz, R. M.
    Worst, T. S.
    Breyer, J.
    Ritter, M.
    Keck, B.
    Boehmer, C.
    Otto, W.
    Eckstein, M.
    Weis, C. A.
    Hartmann, A.
    Bolenz, C.
    Erben, P.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (02): : 467 - 476
  • [6] The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
    Vitale, Silvia R.
    Ruigrok-Ritstier, Kirsten
    Timmermans, A. Mieke
    Foekens, Renee
    Trapman-Jansen, Anita M. A. C.
    Beaufort, Corine M.
    Vigneri, Paolo
    Sleijfer, Stefan
    Martens, John W. M.
    Sieuwerts, Anieta M.
    Jansen, Maurice P. H. M.
    BMC CANCER, 2022, 22 (01)
  • [7] The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
    Silvia R. Vitale
    Kirsten Ruigrok-Ritstier
    A. Mieke Timmermans
    Renée Foekens
    Anita M. A. C. Trapman-Jansen
    Corine M. Beaufort
    Paolo Vigneri
    Stefan Sleijfer
    John W. M. Martens
    Anieta M. Sieuwerts
    Maurice P. H. M. Jansen
    BMC Cancer, 22
  • [8] Methylation ESR1 as a potential factor of resistence to HER2/neu therapy in patients with breast cancer.
    Martinez-Galan, Joaquina
    Gonzalez Rivas, Cynthia S.
    Ruiz Vozmediano, Julia
    Portellano, Lucia
    Ramon Delgado, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [9] PROGNOSTIC AND PREDICTIVE IMPACT OF OBESITY IN HER2 POSITIVE BREAST CANCER
    Parolin, V.
    Fiorio, E.
    Mercanti, A.
    Riolfi, M.
    Cetto, G. L.
    Surmacz, E.
    Molino, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 118 - 118
  • [10] Prognostic and predictive value of HER2/neu oncogene in breast cancer
    Masood, S
    Bui, MM
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (02) : 102 - 108
12345